Come up with a name for your new list and we'll add to it:
InterveXion Therapeutics raised a round of funding on , . Investors include
UAMS Arkansas BioVentures.
InterveXion Therapeutics is a drug discovery and development company focused on antibody-based therapies for treating human disease. The company are developing monoclonal antibodies to treat substance…